| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 6, 2005
Accepted on October 25, 2005
ligand target protein that regulates PPAR-
signaling
Institute for Virus Research, Kyoto University, 53 Shogoin, Kawahara-cho, Sakyo, Kyoto 606-8507, Department of Therapeutic Radiology and Oncology, Kyoto University Graduate School of Medicine, Kyoto University, Yoshida-konoe-cho, Sakyo, Kyoto 606-8501
* To whom correspondence should be addressed. E-mail: hmasutan{at}virus.kyoto-u.ac.jp.
Thioredoxin binding protein-2 (TBP-2), which is identical to Vitamin D3 (VD3) up-regulated protein 1 (VDUP1), plays a crucial role in the integration of glucose and lipid metabolism. There are three highly homologous genes of TBP-2/VDUP1 in humans, but their functions remain unclear. Here, we characterized a TBP-2 homologue, TLIMP (TBP-2 like inducible membrane protein). In contrast to TBP-2, TLIMP displayed no significant binding affinity for thioredoxin. TLIMP exhibited an inner membrane-associated pattern of distribution, and also co-localized with transferrin and low density lipoprotein, indicating endosome- and lysosome-associated functions. VD3 and ligands of peroxisome proliferator-activated receptor-
(PPAR-
), an important regulator of energy metabolism and cell growth inhibition, induced the expression of TLIMP as well as TBP-2. Overexpression of TLIMP suppressed both anchorage-dependent and -independent cell growth and PPAR-
ligand-inducible gene activation. These results suggest that TLIMP, a novel VD3- or PPAR-
ligand-inducible membrane-associated protein, plays a regulatory role in cell proliferation and PPAR-
activation.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |